HYPIEND was presented during the first EDC-MASLD Policy Forum held online on November 19, 2024. Hosted by the ENKORE Cluster project EDC-MASLD, the forum brought together researchers, regulatory experts, and stakeholders to bridge the gap between science and regulatory needs on endocrine-disrupting chemicals (EDCs).
One of the highlights of the forum was the presentation of the updates of the ENKORE Cluster Projects during the panel “Towards next generation risk assessment of EDCs: New methods and tools to inform policymakers”. Eva Serrano Candelas, from the HYPIEND partner ProtoQSAR, presented the prospective methodologies for identifying EDCs co-exposure patterns and for assessing their effects in the development and function of the Hypothalamus-Pituitary axis.
Updates from other ENKORE cluster projects were presented by experts from each project. For MERLON, Marie Louise Holmer from DTU explored ways forward for non-animal methodologies (NAMs) for identifying EDCs. For NEMESIS, Prof. Joan Grimalt from CSIC, offered insights on EDCs exposure assessment and biomarkers.
For EDC-MASLD, You Song from NIVA, presented the utility of Adverse Outcome Pathways (AOPs) in EDCs identification and assessment. Additionally, experts from the EDC-MASLD project presented the latest evidence on the impact of EDC exposure on health outcomes.
The EDC-MASLD project organised an EDC policy forum targeting researchers in the field and public authorities, including EU risk assessment bodies and regulators, supporting them to improve their risk assessment, management, and communication regarding the causal links between EDC exposure and health outcomes. The forum provided input to scientists to help them steer their research, while also identifying concrete policy questions and providing input to those based on EDC-MASLD research.
